| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 3/22/2023 | TFFP TFF Pharmaceuticals | Initiated Coverage | $1.00 | $7.00 | Buy | Low |
| 3/14/2023 | TRVI Trevi Therapeutics | Initiated Coverage | $2.00 | $7.00 | Buy | Low |
| 3/14/2023 | DRRX DURECT | Initiated Coverage | $4.00 | $37.00 | Buy | Low |
| 3/10/2023 | OMGA Omega Therapeutics | Initiated Coverage | $7.00 | $11.00 | Buy | Low |
| 3/9/2023 | CTO CTO Realty Growth | Reiterated Rating | $17.00 | $26.00 | Buy | Low |
| 3/1/2023 | NYMT New York Mortgage Trust | Reiterated Rating | $9.00 | | Buy ➝ Hold | Low |
| 3/1/2023 | BRSP BrightSpire Capital | Reiterated Rating | $6.00 | | Buy ➝ Hold | Low |
| 2/22/2023 | PINE Alpine Income Property Trust | Boost Price Target | $16.00 | $22.00 ➝ $24.00 | Buy | Low |
| 2/10/2023 | MYNZ Mainz Biomed | Initiated Coverage | $6.00 | $11.00 | Buy | Low |
| 1/25/2023 | HAFC Hanmi Financial | Reiterated Rating | $19.00 | $29.00 | Buy | Low |
| 1/20/2023 | CNCE Concert Pharmaceuticals | Reiterated Rating | $8.00 | | Buy ➝ Hold | Low |
| 1/20/2023 | WMC Western Asset Mortgage Capital | Reiterated Rating | $9.00 | $17.50 | Buy | Low |
| 1/17/2023 | GHI Greystone Housing Impact Investors | Reiterated Rating | $17.00 | $22.00 | Buy | Low |
| 1/11/2023 | EURN Euronav | Upgrade | $17.00 | $16.00 | Hold ➝ Buy | Low |
| 1/6/2023 | CTO CTO Realty Growth | Lower Price Target | $17.00 | $27.00 ➝ $26.00 | Buy | Low |
| 1/6/2023 | DCPH Deciphera Pharmaceuticals | Upgrade | $15.00 | | Sell ➝ Hold | Low |
| 12/19/2022 | LFT Lument Finance Trust | Lower Price Target | $2.00 | $3.50 ➝ $3.00 | | Low |
| 12/19/2022 | MITT AG Mortgage Investment Trust | Lower Price Target | $6.00 | $13.00 ➝ $8.00 | | Low |
| 12/19/2022 | EARN Ellington Residential Mortgage REIT | Initiated Coverage | $7.00 | | Hold | Low |
| 12/19/2022 | NYMT New York Mortgage Trust | Lower Price Target | $9.00 | $16.00 ➝ $14.00 | | Low |
| 12/19/2022 | DX Dynex Capital | Boost Price Target | $12.00 | $13.50 ➝ $14.00 | | Low |
| 12/19/2022 | NLY Annaly Capital Management | Initiated Coverage | $19.00 | $22.50 | Buy | Low |
| 12/6/2022 | SACH Sachem Capital | Initiated Coverage | $4.00 | | Hold | N/A |
| 12/5/2022 | BRSP BrightSpire Capital | Initiated Coverage | $6.00 | | Buy | Low |
| 12/2/2022 | AVXL Anavex Life Sciences | Boost Price Target | $9.00 | $40.00 ➝ $80.00 | | Low |
| 11/30/2022 | DARE Daré Bioscience | Initiated Coverage | $1.00 | | Buy | Low |
| 11/30/2022 | THTX Theratechnologies | Initiated Coverage | $1.00 | | Buy | Low |
| 11/30/2022 | SEVN Seven Hills Realty Trust | Initiated Coverage | $10.00 | | Buy | Low |
| 11/30/2022 | PMT PennyMac Mortgage Investment Trust | Downgrade | $12.00 | | Buy ➝ Hold | Low |
| 11/16/2022 | IKT Inhibikase Therapeutics | Downgrade | $1.00 | | Buy ➝ Hold | Low |
| 11/16/2022 | STSA Satsuma Pharmaceuticals | Downgrade | $1.00 | | Buy ➝ Hold | Low |
| 11/7/2022 | HCWB HCW Biologics | Initiated Coverage | $1.00 | $8.00 | Buy | Low |
| 10/25/2022 | PINE Alpine Income Property Trust | Lower Price Target | $16.00 | $23.00 ➝ $22.00 | Buy | Low |
| 10/6/2022 | PSTV Plus Therapeutics | Initiated Coverage | $0.00 | $5.00 | Buy | Low |
| 10/6/2022 | LNTH Lantheus | Initiated Coverage | $81.00 | $104.00 | Buy | Low |
| 9/26/2022 | RMAX RE/MAX | Lower Price Target | $17.00 | $34.00 ➝ $28.00 | Buy | Low |
| 9/22/2022 | ARQT Arcutis Biotherapeutics | Reiterated Rating | $10.00 | $54.00 | Buy | Low |
| 9/13/2022 | MRTX Mirati Therapeutics | Initiated Coverage | $39.00 | $100.00 | Buy | Low |
| 9/6/2022 | FUSN Fusion Pharmaceuticals | Initiated Coverage | $4.00 | | Buy | Low |
| 9/6/2022 | PNT POINT Biopharma Global | Initiated Coverage | $7.00 | | Buy | Low |
| 8/25/2022 | AGLE Aeglea BioTherapeutics | Reiterated Rating | $0.00 | $3.00 | Buy | Low |
| 8/24/2022 | STSA Satsuma Pharmaceuticals | Initiated Coverage | $1.00 | $14.00 | Buy | Low |
| 8/24/2022 | CNCE Concert Pharmaceuticals | Initiated Coverage | $8.00 | $17.00 | Buy | Low |
| 8/24/2022 | IMPL Impel Pharmaceuticals | Initiated Coverage | $1.00 | $26.00 | Buy | Low |
| 8/16/2022 | MDNA Medicenna Therapeutics | Lower Price Target | C$1.00 | C$6.00 ➝ C$5.00 | | N/A |
| 8/4/2022 | NYMT New York Mortgage Trust | Lower Price Target | $9.00 | $17.00 ➝ $16.00 | Buy | N/A |
| 6/28/2022 | KZR Kezar Life Sciences | Boost Price Target | $3.00 | $17.00 ➝ $20.00 | | Low |
| 6/23/2022 | RAIN Rain Oncology | Initiated Coverage | $8.00 | $17.00 | Buy | Low |
| 6/13/2022 | WMC Western Asset Mortgage Capital | Upgrade | $9.00 | | Hold ➝ Buy | High |
| 6/5/2022 | SURF Surface Oncology | Reiterated Rating | $1.00 | $12.00 | Buy | High |
| 6/4/2022 | MRTX Mirati Therapeutics | Reiterated Rating | $39.00 | $100.00 | Buy | Low |
| 6/3/2022 | APS Aptose Biosciences | Reiterated Rating | C$1.00 | C$5.00 | Buy | N/A |
| 5/20/2022 | VBLT Vascular Biogenics | Reiterated Rating | $0.00 | $5.00 | Buy | High |
| 5/16/2022 | AAIC Arlington Asset Investment | Boost Price Target | $3.00 | $5.00 ➝ $6.00 | | N/A |
| 5/6/2022 | PMT PennyMac Mortgage Investment Trust | Lower Price Target | $12.00 | $18.50 ➝ $18.00 | | Low |
| 4/29/2022 | CTO CTO Realty Growth | Boost Price Target | $17.00 | $25.00 ➝ $26.67 | | N/A |
| 4/28/2022 | DX Dynex Capital | Lower Price Target | $12.00 | $20.00 ➝ $19.00 | | Low |
| 4/13/2022 | SURF Surface Oncology | Reiterated Rating | $1.00 | $12.00 | Buy | Low |
| 4/8/2022 | CLNE Clean Energy Fuels | Initiated Coverage | $4.00 | | Buy | Medium |
| 4/8/2022 | FBRT Franklin BSP Realty Trust | Initiated Coverage | $11.00 | $17.00 | Buy | Low |
| 4/1/2022 | SBTX Silverback Therapeutics | Downgrade | $8.00 | | Buy ➝ Hold | High |
| 3/23/2022 | APS Aptose Biosciences | Reiterated Rating | C$1.00 | C$8.00 | Buy | N/A |
| 3/2/2022 | RMAX RE/MAX | Initiated Coverage | $17.00 | $38.00 | Buy | Medium |
| 2/28/2022 | CTO CTO Realty Growth | Boost Price Target | $17.00 | $70.00 ➝ $75.00 | Buy | Medium |
| 2/25/2022 | ORC Orchid Island Capital | Downgrade | $10.00 | | Buy ➝ Hold | Low |
| 2/22/2022 | NYMT New York Mortgage Trust | Lower Price Target | $9.00 | $20.00 ➝ $18.00 | Buy | High |
| 2/7/2022 | DX Dynex Capital | Lower Price Target | $12.00 | $20.50 ➝ $20.00 | Buy | Low |
| 2/2/2022 | CTO CTO Realty Growth | Initiated Coverage | $17.00 | $23.33 | Buy | N/A |
| 2/2/2022 | PINE Alpine Income Property Trust | Initiated Coverage | $16.00 | $23.00 | Buy | Medium |
| 1/26/2022 | HAFC Hanmi Financial | Boost Price Target | $19.00 | $24.00 ➝ $29.00 | Buy | High |
| 1/24/2022 | ORC Orchid Island Capital | Upgrade | $10.00 | $21.25 | Hold ➝ Buy | Low |
| 1/7/2022 | PMT PennyMac Mortgage Investment Trust | Initiated Coverage | $12.00 | $20.50 | Buy | Low |
| 12/6/2021 | BOLT Bolt Biotherapeutics | Reiterated Rating | $1.00 | $45.00 | Buy | High |
| 12/2/2021 | DBTX Decibel Therapeutics | Initiated Coverage | $3.00 | $25.00 | Buy | Medium |
| 11/25/2021 | ALRN Aileron Therapeutics | Reiterated Rating | $1.00 | $5.00 | Buy | High |
| 11/24/2021 | BOLT Bolt Biotherapeutics | Reiterated Rating | $1.00 | $45.00 | Buy | High |
| 11/22/2021 | DCPH Deciphera Pharmaceuticals | Reiterated Rating | $15.00 | | Sell | High |
| 11/19/2021 | MITT AG Mortgage Investment Trust | Lower Price Target | $6.00 | $16.00 ➝ $14.50 | Buy | Low |
| 11/15/2021 | LABP Landos Biopharma | Downgrade | $0.00 | | Buy ➝ Hold | Medium |
| 11/12/2021 | CBIO Catalyst Biosciences | Downgrade | $0.00 | | Buy ➝ Hold | High |
| 10/28/2021 | ARR ARMOUR Residential REIT | Downgrade | $5.00 | | Buy ➝ Hold | Low |
| 10/11/2021 | AY Atlantica Sustainable Infrastructure | Initiated Coverage | $27.00 | $46.00 | Buy | Low |
| 10/4/2021 | AMYT Amryt Pharma | Initiated Coverage | $15.00 | $45.00 | Buy | Low |
| 9/24/2021 | BOLT Bolt Biotherapeutics | Initiated Coverage | $1.00 | $45.00 | Buy | Low |
| 9/23/2021 | LABP Landos Biopharma | Initiated Coverage | $0.00 | $39.00 | Buy | Low |
| 9/16/2021 | SBTX Silverback Therapeutics | Reiterated Rating | $8.00 | $50.00 | Buy | High |
| 9/16/2021 | CRNX Crinetics Pharmaceuticals | Reiterated Rating | $15.00 | $45.00 | Buy | Low |
| 9/13/2021 | ADAP Adaptimmune Therapeutics | Reiterated Rating | $1.00 | $15.00 | Buy | Low |
| 9/10/2021 | CBIO Catalyst Biosciences | Reiterated Rating | $0.00 | $18.00 | Buy | Medium |
| 9/10/2021 | ORC Orchid Island Capital | Upgrade | $10.00 | | Sell ➝ Hold | Low |
| 9/7/2021 | ADAP Adaptimmune Therapeutics | Reiterated Rating | $1.00 | $15.00 | Buy | High |
| 9/3/2021 | SAVA Cassava Sciences | Reiterated Rating | $24.00 | $215.00 | Buy | High |
| 8/25/2021 | SAVA Cassava Sciences | Reiterated Rating | $24.00 | $215.00 | Buy | High |
| 8/24/2021 | SBTX Silverback Therapeutics | Reiterated Rating | $8.00 | $50.00 | Buy | High |
| 8/24/2021 | ACET Adicet Bio | Reiterated Rating | $6.00 | $33.00 | Buy | Low |
| 8/20/2021 | CYAD Celyad Oncology | Reiterated Rating | $1.00 | | Hold | High |
| 8/20/2021 | CLLS Cellectis | Reiterated Rating | $2.00 | $30.00 | Buy | Medium |
| 8/9/2021 | CBIO Catalyst Biosciences | Initiated Coverage | $0.00 | $18.00 | Buy | Low |
| 8/6/2021 | LUMO Lumos Pharma | Reiterated Rating | $3.00 | $25.00 | Buy | Low |
| 7/20/2021 | KZR Kezar Life Sciences | Initiated Coverage | $3.00 | $14.00 | Buy | Medium |
